The impact of European embryonic stem cell patent decisions on research strategies

Article English OPEN
Mahalatchimy, Aurelie ; Rial-Sebbag, Emmanuelle ; Duguet, Anne-Marie ; Taboulet, Florence ; Cambon-Thomsen, Anne (2015)
  • References (16)
    16 references, page 1 of 2

    1. EPO, Enlarged Board of Appeal, WARF, G02/06, November 25, 2008.

    2. Paton, M., Denoon, A. European Intellectual Property Review 33(9), 590-596 (2011).

    3. CJEU, Grand Chamber, Brüstle v Greenpeace eV, C-34/10, October 18, 2011.

    4. Moran, N. Nat. Biotechnol. 29(12), 1057-1059 (2011).

    5. EPO, Boards of Appeal, Technion Research and Development Foundation LTD, T2221/10, February 4, 2014.

    6. Mahalatchimy, A., Rial- Sebbag, E., Duguet, A.- M., Cambon-Thomsen, A., Taboulet, F. European Intellectual Property Review 37(1), 27- 30 (2015). In press.

    7. Harmon, S. H. E., Laurie, G., Courtney, A. European law review 38(1), 92-106 (2013).

    8. Wilmut, I. Cell Stem Cell 9(6), 498 (2011).

    9. European Council. Political agreement on the 7th research framework programme: European Community (2007-2013), Brussels (European Council, 2006).

    10. Bonadio, E. European Intellectual Property Review 34 (7), 433- 443 (2012).

  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    48
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Sussex Research Online - IRUS-UK 0 48
Share - Bookmark